Breakthrough T1D, Eledon Pharmaceuticals, tegoprubart, type 1 diabetes, chronic kidney disease, islet cell transplantation, immunosuppressive therapy, CD40L antibody, insulin independence

New York, New York, U.S., October 21, 2026 Breakthrough T1D has announced the expansion of a funded clinical trial...